

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.89820018 |
| 2 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.68312573 |
| 3 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.68312573 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63690423 |
| 5 | mannosylation (GO:0097502) | 3.60774063 |
| 6 | proteasome assembly (GO:0043248) | 3.55652473 |
| 7 | cytidine deamination (GO:0009972) | 3.47830046 |
| 8 | cytidine metabolic process (GO:0046087) | 3.47830046 |
| 9 | cytidine catabolic process (GO:0006216) | 3.47830046 |
| 10 | metallo-sulfur cluster assembly (GO:0031163) | 3.47812147 |
| 11 | iron-sulfur cluster assembly (GO:0016226) | 3.47812147 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 3.47258200 |
| 13 | response to interferon-beta (GO:0035456) | 3.36165612 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.36008756 |
| 15 | respiratory chain complex IV assembly (GO:0008535) | 3.31272494 |
| 16 | protein complex biogenesis (GO:0070271) | 3.30975245 |
| 17 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.27874245 |
| 18 | pseudouridine synthesis (GO:0001522) | 3.25202470 |
| 19 | rRNA modification (GO:0000154) | 3.19749447 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.19268198 |
| 21 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.17832579 |
| 22 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.16835867 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.15678561 |
| 24 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.13482683 |
| 25 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.11982641 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.11136502 |
| 27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.10888757 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.09193791 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 3.08453477 |
| 30 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05234127 |
| 31 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05234127 |
| 32 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.02395708 |
| 33 | NADH dehydrogenase complex assembly (GO:0010257) | 3.02395708 |
| 34 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.02395708 |
| 35 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.02245593 |
| 36 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.02245593 |
| 37 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.02245593 |
| 38 | negative regulation of ligase activity (GO:0051352) | 3.01895804 |
| 39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.01895804 |
| 40 | protein deneddylation (GO:0000338) | 3.01622681 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.01345805 |
| 42 | B cell mediated immunity (GO:0019724) | 3.01034355 |
| 43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.96491686 |
| 44 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.96218545 |
| 45 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.93933742 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.89949271 |
| 47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.89949271 |
| 48 | negative regulation of B cell apoptotic process (GO:0002903) | 2.89283079 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 2.87309652 |
| 50 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.85237117 |
| 51 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.84143958 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.82456118 |
| 53 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82085798 |
| 54 | adenosine metabolic process (GO:0046085) | 2.81863188 |
| 55 | protein maturation by protein folding (GO:0022417) | 2.81445380 |
| 56 | protein targeting to mitochondrion (GO:0006626) | 2.79410110 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.79321259 |
| 58 | cellular response to interferon-beta (GO:0035458) | 2.78179944 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.78150354 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 2.77956541 |
| 61 | termination of RNA polymerase III transcription (GO:0006386) | 2.75324943 |
| 62 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.75324943 |
| 63 | GMP metabolic process (GO:0046037) | 2.74604009 |
| 64 | positive regulation of ligase activity (GO:0051351) | 2.72521368 |
| 65 | tRNA processing (GO:0008033) | 2.68806453 |
| 66 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.64402060 |
| 67 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.61144821 |
| 68 | establishment of protein localization to mitochondrion (GO:0072655) | 2.58366379 |
| 69 | autophagic vacuole fusion (GO:0000046) | 2.57818951 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 2.56430541 |
| 71 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.55430475 |
| 72 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.53493681 |
| 73 | piRNA metabolic process (GO:0034587) | 2.53129884 |
| 74 | organelle membrane fusion (GO:0090174) | 2.52502157 |
| 75 | protein localization to mitochondrion (GO:0070585) | 2.51525394 |
| 76 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.50670233 |
| 77 | regulation of B cell apoptotic process (GO:0002902) | 2.49897538 |
| 78 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.49536670 |
| 79 | tRNA modification (GO:0006400) | 2.49111598 |
| 80 | cullin deneddylation (GO:0010388) | 2.48451884 |
| 81 | actin nucleation (GO:0045010) | 2.48255127 |
| 82 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.46945422 |
| 83 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.46945422 |
| 84 | positive regulation of protein homooligomerization (GO:0032464) | 2.46130901 |
| 85 | C-terminal protein lipidation (GO:0006501) | 2.42872323 |
| 86 | rRNA methylation (GO:0031167) | 2.42179791 |
| 87 | nucleotide salvage (GO:0043173) | 2.41062212 |
| 88 | protein-cofactor linkage (GO:0018065) | 2.40794021 |
| 89 | GPI anchor biosynthetic process (GO:0006506) | 2.40773208 |
| 90 | mitochondrial RNA metabolic process (GO:0000959) | 2.40704077 |
| 91 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.40473755 |
| 92 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.39884422 |
| 93 | positive regulation of cell cycle arrest (GO:0071158) | 2.39545584 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.37715747 |
| 95 | negative T cell selection (GO:0043383) | 2.37392881 |
| 96 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.36075884 |
| 97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.34841017 |
| 98 | peptidyl-histidine modification (GO:0018202) | 2.34359538 |
| 99 | purine-containing compound salvage (GO:0043101) | 2.33448149 |
| 100 | respiratory electron transport chain (GO:0022904) | 2.33313762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.04532977 |
| 2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.01793183 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.97090020 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.70606651 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.66256773 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40634543 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.39252529 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.37303871 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.14339290 |
| 10 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.87010300 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.79393534 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.76377521 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.60860554 |
| 14 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.60747038 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59083061 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40421390 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.36372351 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.29376986 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28330360 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.27288759 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27098733 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22420101 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21507403 |
| 24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.16034013 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15806592 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.07406148 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05676295 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.04778050 |
| 29 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01683918 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.00917574 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96898120 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91702699 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.90872276 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.89035192 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.87937027 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.84616923 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81446457 |
| 38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77095625 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74521713 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74343466 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.69930368 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66229357 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.59631776 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59128756 |
| 45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56844185 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56287897 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53319811 |
| 48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51565570 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51337519 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46849794 |
| 51 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46443844 |
| 52 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45318724 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44946495 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44276055 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43911297 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40009774 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.39903590 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39851568 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39013427 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.38557980 |
| 61 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37338066 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36228390 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34540606 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.27417941 |
| 65 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26921973 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26662353 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24199265 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22295104 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19929452 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17057753 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.16390275 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12781347 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11658460 |
| 74 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.10007426 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08782921 |
| 76 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08721234 |
| 77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07984685 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06901058 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01637218 |
| 80 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00250578 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96263046 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95632642 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 0.94354363 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93661761 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93360072 |
| 86 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92615850 |
| 87 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90775806 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90598863 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90560869 |
| 90 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89266023 |
| 91 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88986244 |
| 92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.88706655 |
| 93 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88418197 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87651181 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87387455 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87347809 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87280636 |
| 98 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85220181 |
| 99 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84274427 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 0.83812416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.50568337 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.99963212 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.75123815 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 2.61292739 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.45326683 |
| 6 | MP0001800_abnormal_humoral_immune | 2.37581896 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.37152836 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.33962481 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.32260540 |
| 10 | MP0003724_increased_susceptibility_to | 2.31557865 |
| 11 | MP0008058_abnormal_DNA_repair | 2.25185470 |
| 12 | MP0001790_abnormal_immune_system | 2.17085165 |
| 13 | MP0005387_immune_system_phenotype | 2.17085165 |
| 14 | MP0002723_abnormal_immune_serum | 2.16271340 |
| 15 | MP0003786_premature_aging | 2.13590056 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.12325981 |
| 17 | MP0009785_altered_susceptibility_to | 2.10030145 |
| 18 | MP0001819_abnormal_immune_cell | 2.08157524 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.06683420 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.04831143 |
| 21 | MP0003436_decreased_susceptibility_to | 1.95878412 |
| 22 | MP0005025_abnormal_response_to | 1.93200391 |
| 23 | MP0003693_abnormal_embryo_hatching | 1.92407573 |
| 24 | MP0000685_abnormal_immune_system | 1.92158932 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.89061241 |
| 26 | MP0002398_abnormal_bone_marrow | 1.86045736 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.85169047 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.83901733 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.81128579 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.79556695 |
| 31 | MP0002419_abnormal_innate_immunity | 1.74273021 |
| 32 | MP0000716_abnormal_immune_system | 1.70413369 |
| 33 | MP0002722_abnormal_immune_system | 1.64302947 |
| 34 | MP0001764_abnormal_homeostasis | 1.58476553 |
| 35 | MP0005360_urolithiasis | 1.50899489 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.49212388 |
| 37 | MP0003186_abnormal_redox_activity | 1.49118711 |
| 38 | MP0002429_abnormal_blood_cell | 1.49001905 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.47310796 |
| 40 | MP0008007_abnormal_cellular_replicative | 1.45796043 |
| 41 | MP0008260_abnormal_autophagy | 1.45211497 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.43855684 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.43626623 |
| 44 | MP0002405_respiratory_system_inflammati | 1.39306779 |
| 45 | MP0009840_abnormal_foam_cell | 1.37304497 |
| 46 | MP0006082_CNS_inflammation | 1.37026784 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.35412492 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.30973799 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.30570560 |
| 50 | MP0008469_abnormal_protein_level | 1.30290323 |
| 51 | MP0003718_maternal_effect | 1.29700058 |
| 52 | MP0002132_abnormal_respiratory_system | 1.27492106 |
| 53 | MP0002102_abnormal_ear_morphology | 1.26706825 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.26631388 |
| 55 | MP0003787_abnormal_imprinting | 1.26321242 |
| 56 | MP0004147_increased_porphyrin_level | 1.24038709 |
| 57 | MP0003866_abnormal_defecation | 1.23867001 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.14641818 |
| 59 | MP0001853_heart_inflammation | 1.14629301 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.13910066 |
| 61 | MP0001968_abnormal_touch/_nociception | 1.13139964 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.11531497 |
| 63 | MP0001905_abnormal_dopamine_level | 1.09179238 |
| 64 | MP0008995_early_reproductive_senescence | 1.08403328 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.07365201 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.06837613 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.03632390 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.03064095 |
| 69 | MP0002163_abnormal_gland_morphology | 1.01188864 |
| 70 | MP0009764_decreased_sensitivity_to | 1.00459676 |
| 71 | MP0008873_increased_physiological_sensi | 1.00436172 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.99639235 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.97965533 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.96721779 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.94868936 |
| 76 | MP0003077_abnormal_cell_cycle | 0.92411767 |
| 77 | MP0001727_abnormal_embryo_implantation | 0.90336595 |
| 78 | MP0001873_stomach_inflammation | 0.89994436 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 0.88945475 |
| 80 | MP0000358_abnormal_cell_content/ | 0.88159044 |
| 81 | MP0001919_abnormal_reproductive_system | 0.88119024 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.88084097 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.87557486 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.84115221 |
| 85 | MP0001529_abnormal_vocalization | 0.83567839 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.82968444 |
| 87 | MP0005389_reproductive_system_phenotype | 0.82619528 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 0.81593724 |
| 89 | MP0000516_abnormal_urinary_system | 0.81593724 |
| 90 | MP0009763_increased_sensitivity_to | 0.80173004 |
| 91 | MP0002736_abnormal_nociception_after | 0.78802275 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.78346805 |
| 93 | MP0005310_abnormal_salivary_gland | 0.78332294 |
| 94 | MP0000490_abnormal_crypts_of | 0.76855675 |
| 95 | MP0001929_abnormal_gametogenesis | 0.76422135 |
| 96 | MP0002006_tumorigenesis | 0.76166646 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.75317910 |
| 98 | MP0008872_abnormal_physiological_respon | 0.72818195 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.72659289 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.72340481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.07625967 |
| 2 | Stomatitis (HP:0010280) | 3.69689029 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.67606857 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.55160396 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.43340155 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.43340155 |
| 7 | Hepatic necrosis (HP:0002605) | 3.43295258 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.42733451 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.41246871 |
| 10 | Increased CSF lactate (HP:0002490) | 3.39130135 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.11111207 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.09506882 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05856788 |
| 14 | Acute encephalopathy (HP:0006846) | 2.95873646 |
| 15 | Progressive macrocephaly (HP:0004481) | 2.87389796 |
| 16 | Pancytopenia (HP:0001876) | 2.84713479 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 2.77978705 |
| 18 | IgG deficiency (HP:0004315) | 2.75747436 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 2.70361847 |
| 20 | Increased serum lactate (HP:0002151) | 2.68448630 |
| 21 | Methylmalonic aciduria (HP:0012120) | 2.67525748 |
| 22 | Increased intramyocellular lipid droplets (HP:0012240) | 2.66907742 |
| 23 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.66829554 |
| 24 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.66829554 |
| 25 | Abnormal protein glycosylation (HP:0012346) | 2.66829554 |
| 26 | Abnormal glycosylation (HP:0012345) | 2.66829554 |
| 27 | Lactic acidosis (HP:0003128) | 2.66566205 |
| 28 | Methylmalonic acidemia (HP:0002912) | 2.65068567 |
| 29 | Abnormal gallbladder physiology (HP:0012438) | 2.61761321 |
| 30 | Cholecystitis (HP:0001082) | 2.61761321 |
| 31 | Abnormality of B cell number (HP:0010975) | 2.59288453 |
| 32 | B lymphocytopenia (HP:0010976) | 2.57865749 |
| 33 | Ragged-red muscle fibers (HP:0003200) | 2.56278060 |
| 34 | Abnormality of T cells (HP:0002843) | 2.55180485 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.54120683 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.52998432 |
| 37 | Severe combined immunodeficiency (HP:0004430) | 2.52965804 |
| 38 | Petechiae (HP:0000967) | 2.52893230 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.51603718 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.41086777 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.40174880 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.38360007 |
| 43 | Increased IgM level (HP:0003496) | 2.37210901 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.35963238 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35963238 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.34287629 |
| 47 | IgM deficiency (HP:0002850) | 2.33494564 |
| 48 | Prostate neoplasm (HP:0100787) | 2.31885106 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.30869162 |
| 50 | Abnormality of the prostate (HP:0008775) | 2.29698792 |
| 51 | Panhypogammaglobulinemia (HP:0003139) | 2.23537734 |
| 52 | Progressive microcephaly (HP:0000253) | 2.22965965 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.22946839 |
| 54 | Exercise intolerance (HP:0003546) | 2.22338046 |
| 55 | Neutropenia (HP:0001875) | 2.21429314 |
| 56 | T lymphocytopenia (HP:0005403) | 2.20869897 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.18925549 |
| 58 | Hypokinesia (HP:0002375) | 2.17822929 |
| 59 | Cerebral edema (HP:0002181) | 2.17245248 |
| 60 | Oral leukoplakia (HP:0002745) | 2.17099683 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.16190769 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.15598446 |
| 63 | Granulocytopenia (HP:0001913) | 2.14728068 |
| 64 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14249275 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.14249275 |
| 66 | Hyperalaninemia (HP:0003348) | 2.14249275 |
| 67 | Obstructive lung disease (HP:0006536) | 2.10888919 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10888919 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10514769 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10514769 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.09475752 |
| 72 | Recurrent viral infections (HP:0004429) | 2.08979364 |
| 73 | Meningitis (HP:0001287) | 2.05452870 |
| 74 | Microvesicular hepatic steatosis (HP:0001414) | 2.03663478 |
| 75 | Respiratory failure (HP:0002878) | 1.99627625 |
| 76 | Constricted visual fields (HP:0001133) | 1.99293852 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99091830 |
| 78 | Abnormality of eosinophils (HP:0001879) | 1.98337504 |
| 79 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97285660 |
| 80 | Progressive muscle weakness (HP:0003323) | 1.94586997 |
| 81 | Recurrent skin infections (HP:0001581) | 1.93871222 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 1.93033284 |
| 83 | Encephalitis (HP:0002383) | 1.91422627 |
| 84 | Nausea (HP:0002018) | 1.90904240 |
| 85 | Increased serum ferritin (HP:0003281) | 1.90834262 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 1.88603227 |
| 87 | Eosinophilia (HP:0001880) | 1.88080443 |
| 88 | Chronic diarrhea (HP:0002028) | 1.87909685 |
| 89 | Type 2 muscle fiber atrophy (HP:0003554) | 1.87531203 |
| 90 | Tongue fasciculations (HP:0001308) | 1.87438019 |
| 91 | Lethargy (HP:0001254) | 1.85416357 |
| 92 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85233910 |
| 93 | Emotional lability (HP:0000712) | 1.85000304 |
| 94 | Lipid accumulation in hepatocytes (HP:0006561) | 1.84565729 |
| 95 | Renal Fanconi syndrome (HP:0001994) | 1.83567728 |
| 96 | Rough bone trabeculation (HP:0100670) | 1.83390052 |
| 97 | Increased hepatocellular lipid droplets (HP:0006565) | 1.82276895 |
| 98 | Premature ovarian failure (HP:0008209) | 1.82246355 |
| 99 | Hypergonadotropic hypogonadism (HP:0000815) | 1.81933381 |
| 100 | Hypoproteinemia (HP:0003075) | 1.79357711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.33354900 |
| 2 | TXK | 3.24491463 |
| 3 | BCKDK | 3.17330596 |
| 4 | TESK2 | 3.11208708 |
| 5 | VRK2 | 2.99781290 |
| 6 | TAOK3 | 2.87912769 |
| 7 | NME2 | 2.34576871 |
| 8 | PDK2 | 2.31917375 |
| 9 | NUAK1 | 2.30646638 |
| 10 | KDR | 2.16616963 |
| 11 | FES | 1.93660172 |
| 12 | BUB1 | 1.87598320 |
| 13 | RIPK4 | 1.79551214 |
| 14 | TRIM28 | 1.77179791 |
| 15 | MAP3K11 | 1.73255194 |
| 16 | TESK1 | 1.68094969 |
| 17 | PIM2 | 1.64837020 |
| 18 | STK16 | 1.63223469 |
| 19 | INSRR | 1.59490496 |
| 20 | GRK6 | 1.56982593 |
| 21 | SRPK1 | 1.55009412 |
| 22 | VRK1 | 1.54497887 |
| 23 | EIF2AK1 | 1.54231399 |
| 24 | EIF2AK3 | 1.42741788 |
| 25 | MAP3K12 | 1.41793060 |
| 26 | CDK19 | 1.33525374 |
| 27 | TBK1 | 1.29596912 |
| 28 | IKBKB | 1.23407298 |
| 29 | SYK | 1.22933334 |
| 30 | MAP4K2 | 1.21822987 |
| 31 | TEC | 1.17605146 |
| 32 | MST4 | 1.14692290 |
| 33 | ITK | 1.13146927 |
| 34 | TNK2 | 1.12326834 |
| 35 | CDK9 | 1.12240856 |
| 36 | IKBKE | 1.11836904 |
| 37 | KIT | 1.11494411 |
| 38 | AURKA | 1.11380910 |
| 39 | ARAF | 1.10687816 |
| 40 | LYN | 1.08111273 |
| 41 | SIK3 | 1.07729906 |
| 42 | BTK | 1.05578332 |
| 43 | DAPK1 | 1.05450542 |
| 44 | ZAK | 1.02815731 |
| 45 | LIMK1 | 1.02503622 |
| 46 | TLK1 | 0.98431387 |
| 47 | CSNK1G3 | 0.93860962 |
| 48 | CCNB1 | 0.93521665 |
| 49 | SCYL2 | 0.92065548 |
| 50 | IRAK4 | 0.90491212 |
| 51 | LCK | 0.89761683 |
| 52 | JAK3 | 0.86884917 |
| 53 | BLK | 0.86855049 |
| 54 | TYK2 | 0.86528963 |
| 55 | MAP3K14 | 0.86366767 |
| 56 | CSF1R | 0.83893273 |
| 57 | PRKCQ | 0.83023474 |
| 58 | RPS6KA5 | 0.82172309 |
| 59 | RPS6KB2 | 0.81270946 |
| 60 | ADRBK2 | 0.80387737 |
| 61 | MARK3 | 0.77940026 |
| 62 | MAPKAPK3 | 0.77136142 |
| 63 | MAP2K7 | 0.74228028 |
| 64 | MATK | 0.74055405 |
| 65 | MAP2K2 | 0.73007225 |
| 66 | MUSK | 0.72690812 |
| 67 | PRKCI | 0.71764908 |
| 68 | GRK1 | 0.69906568 |
| 69 | NME1 | 0.66701536 |
| 70 | PIK3CG | 0.65193375 |
| 71 | MAP2K3 | 0.63505986 |
| 72 | ATR | 0.63247300 |
| 73 | PLK4 | 0.63139431 |
| 74 | CSNK1A1L | 0.60754538 |
| 75 | HCK | 0.60585350 |
| 76 | CSNK2A1 | 0.60502847 |
| 77 | PIM1 | 0.60042608 |
| 78 | CDK8 | 0.59701056 |
| 79 | BRSK1 | 0.59576915 |
| 80 | MAP3K3 | 0.58313242 |
| 81 | ZAP70 | 0.58150788 |
| 82 | RAF1 | 0.56330192 |
| 83 | SIK2 | 0.55113794 |
| 84 | IRAK3 | 0.51645486 |
| 85 | BMPR2 | 0.51112529 |
| 86 | MAPK11 | 0.49808919 |
| 87 | CSNK1G1 | 0.49659731 |
| 88 | MAP3K5 | 0.48650367 |
| 89 | CSK | 0.48597076 |
| 90 | ERN1 | 0.47461175 |
| 91 | CSNK1G2 | 0.47198768 |
| 92 | GRK7 | 0.46860489 |
| 93 | CLK1 | 0.45419595 |
| 94 | PAK1 | 0.44981400 |
| 95 | * CSNK2A2 | 0.44566265 |
| 96 | STK10 | 0.44252262 |
| 97 | NEK1 | 0.43275381 |
| 98 | FRK | 0.42962798 |
| 99 | FGR | 0.41078851 |
| 100 | MAPKAPK5 | 0.40940306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.10559959 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.00838635 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.70047222 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.45378533 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.40424624 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.35120564 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.26181632 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23207411 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21319765 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.20194412 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19396984 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.16729019 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16573521 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.05183410 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84430795 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.81396303 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81034093 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.74425275 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74357002 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71269498 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.68166610 |
| 22 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.66206918 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64859051 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.55881910 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53429942 |
| 26 | DNA replication_Homo sapiens_hsa03030 | 1.50209862 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.36444114 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35218712 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31127843 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.29909757 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28336383 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.23097716 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22873552 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.20493138 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18189108 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 1.15923760 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.15302791 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.14238948 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13159770 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12357089 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11197664 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09731078 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08768024 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08675554 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07110189 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06381948 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04251292 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00184437 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97561325 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92457877 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92112843 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.90806850 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87877721 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87638930 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.85210024 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.81786269 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79069551 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.78923607 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78385079 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.74632401 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73474973 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72353807 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71046340 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70625977 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.70076030 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.68857694 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68487757 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.67075187 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65797548 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.64529860 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61934328 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61173492 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59799453 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58422697 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58086635 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57285440 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54690556 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53502956 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52885693 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49918673 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49644755 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48862370 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48511282 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48109089 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47999677 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.45977616 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44624313 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43328013 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43280303 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42195526 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41756130 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.40948979 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40328132 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35979112 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.34806100 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34708383 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34693325 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34664550 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34345314 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.33725107 |

